EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
By Dagmar E. Ehrnhoefer, J. Bieschke, A. Boeddrich, M. Herbst, L. Masino, R. Lurz, S. Engemann, A. Pastore, Erich E. Wanker. Nature Structural &Molecular Biology, 2008
1,398 citations recorded by the source corpus.
Subfields: Complementary and alternative medicine, Neurology, Physiology
View Paper: https://www.semanticscholar.org/paper/4fcd27b38b8fafbc7f722fd95091d4bb34d24abe
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Bieschke
- Jenny Russ
- R. Friedrich
- Heike J Wobst
- K. Neugebauer
- Erich E. Wanker
- Dagmar E. Ehrnhoefer
- L. Breydo
Citations in the corpus
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity (2010, methodology): “The membrane was then stained with NBT, a substance that specifically detects EGCG-bound polypeptide chains (6).”